Labetalol Oral: Dosing and Precautions
Labetalol guidance for hypertension in pregnancy, with beta-blocker precautions and neonatal monitoring advice.
Also searched as
Source reviewed
March 2024
Guide category
Oral drugs
Safety boundary
Prescription medicine information for clinician-guided use.
Kenza Health Hub presents this medicine page as structured health education. Check dose, route, interactions, pregnancy or breast-feeding considerations, and local protocol with a qualified clinician or pharmacist. Read our medical editorial policy.
Therapeutic action
Non cardioselective beta-blocker.
Indications
Hypertension in pregnancy.
Forms and strengths
- 100 mg and 200 mg tablets.
Dose
- 100 mg 2 times daily.
- Increase if necessary in 100 to 200 mg increments until an effective dose is reached, usually 400 to 800 mg daily, maximum 2400 mg daily.
- If higher doses are required, give in 3 divided doses.
Duration
According to clinical response. Do not stop treatment abruptly; decrease doses gradually.
Contra-indications, adverse effects, precautions
- Do not administer to patients with asthma, chronic obstructive bronchopneumonia, heart failure, severe hypotension, bradycardia under 50/minute, atrio-ventricular heart blocks, Raynaud's syndrome, or hepatic impairment.
- May cause bradycardia, hypotension, heart failure, bronchospasm, hypoglycaemia, gastrointestinal disturbances, dizziness, headache, weakness, and urinary retention.
- Administer with caution to patients with diabetes because of the risk of hypoglycaemia.
- Reduce dosage in patients with renal impairment.
- In the event of anaphylactic shock, there is a risk of resistance to epinephrine.
- Avoid or monitor combination with mefloquine, digoxin, amiodarone, diltiazem, verapamil, tricyclic antidepressants, antipsychotics, and other antihypertensive drugs.
- Do not administer simultaneously with antacids; administer 2 hours apart.
- Monitor the neonate for hypoglycaemia, bradycardia, and respiratory distress during the first 24 to 72 hours after birth.
- Breast-feeding: no contra-indication.
Source
MSF Essential drugs practical guidelines (January 2026)
This page combines source-derived medicine reference sections with Kenza editorial context, while leaving out the Storage and Remarks sections from the source batch.
Rate this guide
Be the first to rate this guide.
